X4 Pharmaceuticals Inc
NASDAQ:XFOR

Watchlist Manager
X4 Pharmaceuticals Inc Logo
X4 Pharmaceuticals Inc
NASDAQ:XFOR
Watchlist
Price: 3.4 USD -3.41% Market Closed
Market Cap: 19.7m USD

Intrinsic Value

XFOR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one XFOR stock under the Base Case scenario is 100.67 USD. Compared to the current market price of 3.4 USD, X4 Pharmaceuticals Inc is Undervalued by 97%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

XFOR Intrinsic Value
100.67 USD
Undervaluation 97%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about X4 Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
X4 Pharmaceuticals Inc

Current Assets 95.7m
Cash & Short-Term Investments 87m
Receivables 1.2m
Other Current Assets 7.6m
Non-Current Assets 34.3m
PP&E 4.1m
Intangibles 27.2m
Other Non-Current Assets 3m
Efficiency

Free Cash Flow Analysis
X4 Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
X4 Pharmaceuticals Inc

Revenue
31.4m USD
Cost of Revenue
-5.5m USD
Gross Profit
25.9m USD
Operating Expenses
-34.4m USD
Operating Income
-8.6m USD
Other Expenses
23.2m USD
Net Income
14.6m USD
Fundamental Scores

XFOR Profitability Score
Profitability Due Diligence

X4 Pharmaceuticals Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional ROE
ROE is Increasing
ROIC is Increasing
38/100
Profitability
Score

X4 Pharmaceuticals Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

XFOR Solvency Score
Solvency Due Diligence

X4 Pharmaceuticals Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
31/100
Solvency
Score

X4 Pharmaceuticals Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XFOR Price Targets Summary
X4 Pharmaceuticals Inc

There are no price targets for XFOR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

X4 Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for XFOR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

XFOR Insider Trading
Buy and sell transactions by insiders